MariMed (OTCMKTS:MRMD – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 2.75% and a negative net margin of 10.97%.
MariMed Stock Performance
Shares of OTCMKTS:MRMD traded up $0.00 on Wednesday, hitting $0.12. The company’s stock had a trading volume of 937,712 shares, compared to its average volume of 404,236. The company has a market capitalization of $43.87 million, a price-to-earnings ratio of -2.88 and a beta of 2.69. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55. MariMed has a 12 month low of $0.11 and a 12 month high of $0.34. The stock’s 50-day moving average is $0.12 and its two-hundred day moving average is $0.15.
MariMed Company Profile
Featured Stories
- Five stocks we like better than MariMed
- How to Profit From Growth Investing
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- 3 Small Caps With Big Return Potential
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How to trade using analyst ratings
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.